≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Adenocarcinomas of cervix

Endpoint Browser PheWeb

C3_CERVIX_ADENO

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

only females

293218

2. Check conditions

None

293218

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C53
  • Cancer registry: Morphology ICD-O-3 — 8140
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

153

4. Check minimum number of events

None

153

5. Include endpoints

None

153

6. Filter based on genotype QC (FinnGen only)

145

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 145 145 -
Unadjusted period prevalence (%) 0.05 0.05 -
Median age at first event (years) 43.00 43.00 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
153
Matched controls
1530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
127.6
104
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
118.7
98
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
26.5
84.0
69
46
ULA02
NOMESCO Finland
Kolposcopy
15.1
66.9
94
146
128
Kela drug reimbursment
Cancers of female genital organs
+∞
56.9
51
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
12.0
55.4
91
167
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
50.9
46
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.7
44.2
75
138
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
40.4
37
*
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
39.3
36
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
38.1
35
*
JN4BD
NOMESCO Finland
Extensive body CT
15.4
37.3
36
30
H02AB02
ATC
dexamethasone; systemic
100.1
35.7
38
5
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
8.7
34.0
55
93
B01AB10
ATC
tinzaparin; parenteral
9.4
31.1
44
63
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
30.2
28
*
LEB00
NOMESCO Finland
Biopsy of vagina
40.1
29.8
37
12
LDA10
NOMESCO Finland
Curettage of cervix uteri
10.3
29.1
37
46
XX3DW
NOMESCO Finland
Time consuming IT work
12.6
28.0
30
29
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
12.5
27.1
29
28
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
11.7
25.8
29
30
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
+∞
25.7
24
*
LCD30
NOMESCO Finland
Radical hysterectomy
+∞
24.6
23
*
ZXC96
NOMESCO Finland
Robot assisted procedure
103.7
24.5
26
*
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
23.5
22
*
WF002
NOMESCO Finland
Radical radiotherapy
74.0
22.6
25
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
21.7
62
175
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
70.5
21.6
24
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
21.3
20
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
67.1
20.5
23
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
19.2
18
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
19.2
18
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
21.5
18.6
27
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.2
18.2
27
16
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
18.1
17
*
A04AA02
ATC
granisetron; systemic, transdermal
202.5
17.9
18
*
A04AA01
ATC
ondansetron; systemic, rectal
16.0
17.9
29
22
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
17.5
79
309
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
17.0
16
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
189.8
16.8
17
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
28.3
16.5
22
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
95.1
15.9
17
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
15.9
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
177.4
15.8
16
*
UKC02
NOMESCO Finland
Cystoscopy
5.3
15.3
36
84
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
14.8
14
*
B01AB05
ATC
enoxaparin; parenteral
3.8
14.6
73
299
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.7
13
*
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
13.7
13
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
13.7
13
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
31.6
13.3
17
6
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
12.7
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.7
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.7
12
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
10.3
12.3
24
27
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
12.2
27
59
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
11.7
51
187
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.6
11
*
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
11.6
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
11.6
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
11.6
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
129.3
11.6
12
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.7
11.1
43
145
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
117.8
10.6
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.5
10
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
10.5
10
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.1
10.3
16
11
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.1
10.3
16
11
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
9.5
9
*
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
9.5
9
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
9.5
9
*
LCA06
NOMESCO Finland
Biopsy of endometrium
3.4
9.4
42
154
Z51.5
ICD-10 Finland
Palliative care
12.6
9.3
16
14
ZXE20
NOMESCO Finland
More than three and less than five hours
3.9
9.2
30
89
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
8.5
84
473
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
8.4
8
*
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
8.4
8
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
8.4
8
*
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
8.4
8
*
WZC30
NOMESCO Finland
Teaching
3.8
8.1
27
81
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.1
7.9
12
8
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
47.4
7.8
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
47.4
7.8
9
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
47.4
7.8
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
7.7
19
45
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.4
7.6
16
21
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.3
7.5
21
55
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.3
7.5
12
9
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
84.0
7.5
8
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
7.3
7
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
7.3
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
LBE10
NOMESCO Finland
Bilateral salpingectomy
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
7.0
40
167
JN4AD
NOMESCO Finland
Body CT examination
6.5
6.8
17
29
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
42.0
6.8
8
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
15.2
6.5
10
7
WW500
NOMESCO Finland
Blood transfusion
8.8
6.5
13
16
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
72.8
6.5
7
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
72.8
6.5
7
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
6.1
32
127
J01EA01
ATC
trimethoprim; systemic
2.4
6.1
64
358

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
42
29
19.58
48.72
1.7
1.2
—
—
—
0
0
17
6
31.58
13.27
1.1
1.0
—
—
—
0
0
57
238
3.22
10.44
4.2
3.4
—
—
—
0
0
22
30
8.38
10.14
1.6
1.8
—
—
—
0
0
89
487
2.98
9.97
2.8
1.7
—
—
—
0
0
69
344
2.83
8.97
2.2
1.9
—
—
—
0
0
104
649
2.88
8.64
6.4
5.0
0.00
0.00
estimate
-0.00
25
109
91
533
2.75
8.52
3.9
3.4
6.67
5.87
ph
—
6
39
32
106
3.55
8.33
1.4
1.1
—
—
—
0
0
103
653
2.77
8.07
4.8
3.6
0.00
0.00
estimate
-0.00
24
110
106
682
2.80
8.06
12.9
7.0
3.84
4.22
e9/l
0.90
98
588
76
432
2.51
7.21
4.9
3.6
117.87
110.35
e6/l
0.05
53
280
100
648
2.57
7.12
4.8
3.7
0.00
0.00
estimate
-0.00
26
117
75
426
2.49
7.10
4.9
3.1
—
—
—
0
0
51
243
2.65
6.96
2.6
2.4
9.14
7.29
e6/l
0.42
41
211
79
472
2.39
6.55
6.6
3.7
34.62
36.64
g/l
2.13
73
437
19
52
4.03
6.43
3.6
1.6
2.91
3.14
ug/l
0.11
14
38
60
320
2.44
6.38
3.7
2.6
—
—
—
0
0
9
5
18.99
6.34
1.0
1.0
—
—
—
0
0
63
348
2.38
6.15
3.8
3.0
30.78
51.97
e6/l
0.51
51
250
56
294
2.43
6.12
4.6
3.7
—
—
—
0
0
118
864
2.60
5.92
6.5
4.8
2651.83
2123.79
e6/l
—
6
14
60
331
2.34
5.82
5.1
4.0
0.00
0.00
estimate
-0.00
24
112
88
571
2.27
5.78
7.4
3.4
7.93
10.06
umol/l
3.07
83
530
53
285
2.32
5.39
11.1
5.6
—
—
—
0
0
57
317
2.27
5.35
3.8
2.7
0.54
0.49
e6/l
0.10
45
222
121
921
2.50
5.17
8.9
5.1
81.87
75.72
u/l
0.51
115
838
23
84
3.05
5.04
3.0
2.3
0.25
0.21
g/l
1.78
23
78
56
338
2.04
4.09
1.7
1.5
—
—
—
0
0
23
98
2.59
3.80
3.8
3.3
—
—
—
0
0
91
664
1.91
3.71
3.3
3.6
6.27
6.49
mmol/l
0.56
83
600
23
100
2.53
3.64
5.8
3.2
—
—
—
0
0
115
923
1.99
3.35
6.7
4.3
—
—
—
0
0
72
502
1.82
3.26
4.5
4.2
1.22
1.22
mmol/l
0.21
64
450
108
856
1.89
3.18
3.2
3.3
—
—
—
0
0
16
62
2.77
3.16
2.4
4.6
—
—
—
0
0
67
474
1.74
2.78
7.2
12.1
1.07
1.29
inr
3.08
20
143
73
532
1.71
2.70
11.1
7.6
0.00
0.00
e9/l
1.09
61
428
39
239
1.85
2.60
2.8
2.4
503.18
540.02
mosm/kgh2o
0.43
33
194
31
176
1.95
2.59
3.3
2.7
2.58
5.35
e6/l
1.18
19
87
24
124
2.11
2.58
1.4
1.2
—
—
—
0
0
14
57
2.60
2.53
3.8
4.6
—
—
—
0
0
0
67
0.00
2.46
0.0
1.1
—
—
—
0
0
6
12
5.15
2.42
1.2
1.3
—
—
—
0
0
42
273
1.74
2.29
5.0
2.8
99.93
94.30
%
0.84
42
261
11
44
2.62
2.06
4.5
5.9
—
—
—
0
0
19
98
2.07
2.06
3.7
5.1
0.69
1.53
mmol/l
0.58
12
80
46
316
1.65
2.03
2.5
2.1
3.56
3.03
mg/l
0.50
40
273
74
571
1.57
2.02
5.7
4.5
1.21
1.23
mmol/l
0.63
60
500
80
629
1.57
2.01
5.0
5.6
1.56
1.91
e9/l
4.17
69
557
78
613
1.56
1.94
5.1
5.5
0.51
0.55
e9/l
0.70
68
533
141
1287
2.22
1.94
18.7
10.9
31.13
19.19
mg/l
2.87
120
960
78
616
1.54
1.88
5.1
5.5
0.03
0.04
e9/l
3.05
67
532
74
578
1.54
1.88
5.4
6.0
—
—
—
0
0
6
17
3.63
1.85
1.5
1.8
—
—
—
0
0
11
47
2.44
1.82
3.0
5.3
0.72
0.68
%
0.14
11
47
11
47
2.44
1.82
3.0
5.3
1.25
1.30
%
0.08
11
47
116
1283
0.60
1.81
3.5
4.0
1.63
1.58
mmol/l
0.61
108
1194
117
1291
0.60
1.79
3.5
4.1
4.95
4.77
mmol/l
1.14
109
1207
20
114
1.87
1.66
5.7
3.8
105.30
104.03
mmol/l
0.58
20
114
13
63
2.16
1.65
3.2
2.5
368.86
2671.63
u/l
—
7
26
5
14
3.65
1.63
1.4
1.6
—
—
—
0
0
10
43
2.42
1.62
3.2
5.7
96.85
94.74
%
—
10
43
79
641
1.48
1.60
5.4
6.1
0.16
0.18
e9/l
1.02
69
564
14
72
2.04
1.54
2.1
4.2
1.21
1.26
mmol/l
0.09
14
72
7
27
2.67
1.53
2.6
2.9
4.01
3.71
mmol/l
—
7
27
14
74
1.98
1.44
2.4
2.7
74.83
69.84
e9/l
—
9
58
24
152
1.69
1.42
2.1
1.9
—
—
—
0
0
121
1311
0.63
1.41
3.9
4.6
2.89
2.81
mmol/l
0.41
112
1222
49
375
1.45
1.29
4.2
3.0
—
—
—
0
0
16
94
1.78
1.23
2.4
2.5
—
—
—
0
0
5
19
2.68
1.22
1.2
1.0
—
—
—
0
0
107
1179
0.69
1.22
4.3
5.3
37.65
38.81
mmol/mol
0.66
100
1102
8
151
0.50
1.22
1.4
1.3
—
—
—
0
0
6
26
2.36
1.20
3.2
1.7
—
—
—
0
0
46
357
1.41
1.11
3.3
2.8
7.39
7.40
ph
—
10
49
7
32
2.24
1.09
3.0
4.1
—
—
—
0
0
143
1355
1.85
1.06
21.9
11.7
71.81
68.01
umol/l
1.07
143
1355
41
314
1.42
1.06
1.4
1.5
21.34
22.54
nmol/l
0.20
34
273
7
34
2.11
1.04
2.0
1.7
1.08
1.38
ug/l
—
7
26
7
35
2.05
1.01
2.6
2.7
1.29
1.27
mmol/l
—
7
35
0
29
0.00
0.99
0.0
1.1
—
—
—
0
0
114
1230
0.71
0.98
3.1
3.7
1.31
1.19
mmol/l
1.19
105
1132
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
143
1366
1.72
0.86
17.4
10.6
—
—
—
0
0
119
1266
0.73
0.81
3.9
4.2
5.61
5.76
mmol/l
0.93
110
1163
19
132
1.50
0.80
1.7
1.6
—
—
—
0
0
0
24
0.00
0.80
0.0
1.1
—
—
—
0
0
14
91
1.59
0.78
1.6
1.2
—
—
—
0
0
52
435
1.30
0.75
3.2
3.3
28.64
20.48
ng/l
0.38
29
254
7
39
1.83
0.73
4.6
4.2
—
—
—
0
0
9
58
1.59
0.71
4.2
3.7
—
7.41
—
0
8
14
94
1.54
0.69
4.0
3.2
4.28
4.52
pmol/l
0.41
14
84
7
43
1.66
0.68
2.1
2.3
1.21
1.51
g/l
—
7
38
28
351
0.75
0.64
1.5
1.6
1.33
1.32
mmol/l
0.03
23
299
143
1379
1.57
0.63
12.7
8.3
22.13
22.58
u/l
0.18
138
1324
22
285
0.73
0.63
1.2
1.3
150.50
34.37
iu/ml
—
6
90
28
220
1.33
0.63
4.4
3.9
482.95
67.31
ng/l
0.66
22
153
12
173
0.67
0.62
1.2
1.4
—
—
—
0
0
27
219
1.28
0.49
1.4
1.7
—
—
—
0
0
23
283
0.78
0.47
1.1
1.3
46.73
8.82
u/ml
—
7
116
9
127
0.69
0.45
1.1
1.2
—
—
—
0
0
5
31
1.63
0.43
3.6
1.2
157.60
229.92
ug/l
—
5
26
18
141
1.31
0.42
1.2
1.5
—
—
—
0
0
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
12.92
—
0
16
7
102
0.67
0.41
1.3
1.3
—
29.16
—
0
5
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
8
61
1.33
0.40
1.1
1.3
—
—
—
0
0
39
339
1.20
0.40
1.5
1.3
0.62
1.16
u/ml
1.09
18
93
16
202
0.77
0.40
1.3
1.3
—
572.44
—
0
45
13
98
1.36
0.39
3.3
3.5
—
—
—
0
0
32
274
1.21
0.38
1.3
1.9
—
—
—
0
0
11
81
1.39
0.37
1.2
1.3
—
—
—
0
0
5
79
0.62
0.36
1.2
3.2
4.80
8.64
e9/l
—
5
64
6
42
1.45
0.36
1.7
1.6
19.50
20.29
s
—
6
35
6
42
1.45
0.36
1.3
1.1
—
—
—
0
0
6
88
0.67
0.34
1.2
1.4
—
—
—
0
0
29
334
0.84
0.33
4.1
3.2
106.14
473.63
mg/l
0.61
20
199
18
147
1.25
0.32
1.3
1.3
—
—
—
0
0
7
99
0.69
0.32
1.1
1.7
—
—
—
0
0
31
353
0.85
0.31
5.1
3.7
22.20
5.23
mg/mmol
0.98
22
206
33
372
0.86
0.29
4.0
3.0
6.25
6.87
mmol/l
0.60
27
303
58
534
1.14
0.29
2.0
1.9
96.19
98.07
pmol/l
0.12
30
265
5
71
0.69
0.26
1.4
1.4
—
—
—
0
0
124
1273
0.86
0.24
5.6
5.1
1.94
1.79
mu/l
0.25
113
1178
5
37
1.36
0.24
4.0
6.3
24.20
24.84
mmol/l
—
5
37
7
92
0.75
0.23
2.1
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.2
—
58.60
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
1.94
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
118.83
—
0
12
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
338.69
—
0
13
9
115
0.77
0.20
1.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
107
1100
0.91
0.17
5.1
4.3
14.59
14.46
pmol/l
0.23
97
1015
50
475
1.08
0.13
2.2
2.8
—
—
—
0
0
5
43
1.17
0.10
3.2
1.8
—
—
—
0
0
27
288
0.92
0.09
1.6
1.3
1.92
2.33
g/l
1.35
14
171
14
155
0.89
0.09
2.1
1.9
—
—
—
0
0
29
308
0.93
0.09
2.9
3.5
—
—
—
0
0
6
72
0.83
0.08
2.2
2.5
—
—
—
0
0
8
77
1.04
0.07
2.4
2.4
—
—
—
0
0
30
296
1.02
0.00
2.0
1.7
3.48
0.96
mg/l
0.50
22
225
19
187
1.02
0.00
1.1
1.2
—
—
—
0
0
17
175
0.97
0.00
1.4
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
2.8
—
19.04
—
0
9
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
11.33
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
967.83
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
23.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
48.22
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
27.43
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
8.33
—
0
6
144
1438
1.02
-0.00
28.9
16.6
38.16
39.47
%
3.67
138
1348
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
134.67
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
8.9
—
0.72
—
0
7
7
76
0.92
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
127.00
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
7.40
—
0
5
7
74
0.94
-0.00
1.7
1.4
449.00
321.84
mu/l
—
7
64

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_CERVIX_ADENO – Adenocarcinomas of cervix

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).